Preferred Label : mRNA-derived Lung Cancer Vaccine BI 1361849;
NCIt definition : A non-small cell lung cancer (NSCLC) vaccine containing six modified mRNAs, which
encode six different NSCLC associated antigens, with potential antitumor and immunomodulatory
activities. Upon intradermal administration, mRNA-derived lung cancer vaccine BI 1361849
may stimulate the immune system to mount both humoral and cellular responses against
NSCLC cells. The six tumor-associated antigens (TAAs) encoded by these mRNAs are frequently
expressed by NSCLC cells and are minimally expressed or absent in normal, healthy
cells.;
Molecule name : CV9202; BI 1361849; BI1361849;
NCI Metathesaurus CUI : CL453982;
Origin ID : C111574;
UMLS CUI : C4724798;
Semantic type(s)
- concept_is_in_subset
